Advertisement
The cooperation is based on capital contribution by the Chinese party --Changzhou Fangyuan Pharmaceutical Co. Ltd. and technological patent of Russianparty -- IMDi Co., Ltd. Changzhou Fangyuan Pharmaceutical Co. Ltd will makeuse of the existing technology of IMDi to produce enzyme-linked immunosorbentassay (ELISA) reagent and biological chips. According to the contract, theproducts will be put into production in Changzhou high-tech district and puton to the market this year.
Advertisement
''The disease can be diagnosed quickly through a drop of blood of thepatient in some ten minutes or several hours'', according to principal ofFangyuan Pharmaceutical Co. Ltd. Enzyme-linked immunosorbent assay technologycan rapidly screens and quantitatively detects the existing of antigen in asample, clinically. It mainly targets on the regular check and diagnosis ofchlamydia, neisseria gonorrhoeae, herpes viruses, AIDS, and virus of hepatitisA, B, and C.
Biological chips technology is a new technology that is rapidly developedin the field of life science in recent years. The technological features ofthis Sino-Russian cooperation are its strong specificity and high sensitivity.It can carry out early diagnosis of the disease, so as to free the patientfrom the worries of waiting long period for the inspection results and morehelpful to prevent and cure the disease. The pregnancy diagnosis reagent foridentifying whether the embryo has suffered from congenital disease hasreached international standards, and is mainly used for diagnosis of variousinheritable diseases, tumour, viral and other diseases.
It is known that IMDi Co., Ltd has started the scientific development ofenzyme-linked immunosorbent assay since 1994. It boasts one of the leadingenterprises among enzyme-linked immunosorbent reagents manufacturers. Whilethe research and develop of enzyme-linked immunosorbent reagents in China isjust at the beginning, the quality of the reagent product is not stable henceunable to clinically applied in large scale. The implementation of the projectwill increase the stability of Chinese enzyme-linked immunosorbent reagents,expand it application area, promote the development of Chinese immunityanalysis technology and make a domestic breakthrough.For more information, please contact: Wang Zhongliang Department of Propaganda and United Front Work Changzhou National High-Tech District, Jiangsu Province Tel: +86-519-8512-7305 or +86-130-925-27003 Fax: +86-519-8511-5905 Email: [email protected]
SOURCE Changzhou National High-Tech District, Jiangsu Province
